Pro-Dex Inc Asset Resilience Ratio

Latest as of December 2025: 1.39%

Pro-Dex Inc asset resilience ratio. Pro-Dex Inc (PDEX) has an Asset Resilience Ratio of 1.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Pro-Dex Inc (PDEX) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$864.00K
Cash + Short-term Investments

Total Assets

$62.26 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Pro-Dex Inc (2001–2025)

Asset resilience ratio of Pro-Dex Inc from 2001 to 2025. This chart shows how Pro-Dex Inc's Asset Resilience Ratio has changed over time. Read debt load of Pro-Dex Inc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Pro-Dex Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Pro-Dex Inc (PDEX) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $864.00K 1.39%
Total Liquid Assets $864.00K 1.39%

Asset Resilience Insights

  • Limited Liquidity: Pro-Dex Inc maintains only 1.39% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Pro-Dex Inc Industry Peers by Asset Resilience Ratio

Compare Pro-Dex Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.55%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Pro-Dex Inc Asset Resilience Ratio by Year (2001–2025)

Pro-Dex Inc asset resilience ratio by year from 2001 to 2025. The table below shows the annual Asset Resilience Ratio data for Pro-Dex Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 11.01% $6.74 Million $61.19 Million +2.98pp
2024-06-30 8.04% $4.22 Million $52.48 Million +5.85pp
2023-06-30 2.19% $1.13 Million $51.82 Million +0.65pp
2022-06-30 1.54% $755.00K $49.09 Million 0.00pp
2021-06-30 1.54% $755.00K $49.09 Million -6.69pp
2020-06-30 8.22% $2.56 Million $31.13 Million -2.16pp
2019-06-30 10.38% $2.65 Million $25.52 Million -0.77pp
2018-06-30 11.15% $2.22 Million $19.92 Million +6.76pp
2017-06-30 4.39% $718.00K $16.35 Million --
2016-06-30 0.00% $0.00 $11.15 Million --
2015-06-30 0.00% $0.00 $12.52 Million --
2014-06-30 0.00% $0.00 $11.71 Million --
2013-06-30 0.00% $0.00 $10.60 Million --
2012-06-30 0.00% $0.00 $12.82 Million --
2002-06-30 7.93% $790.00K $9.97 Million -10.50pp
2001-06-30 18.43% $2.16 Million $11.74 Million --
pp = percentage points

About Pro-Dex Inc

NASDAQ:PDEX USA Medical Instruments & Supplies
Market Cap
$193.13 Million
Market Cap Rank
#17213 Global
#4088 in USA
Share Price
$60.24
Change (1 day)
+4.49%
52-Week Range
$28.91 - $73.41
All Time High
$73.41
About

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory… Read more